Subsequently, the Kaplan–Meier curve and statistical tests revealed a significantly lower OS rate for patients with glioma presenting high hepcidin expression than that of patients with low hepcidin expression in the four glioma datasets (Figure 2). The gene discussed is HAMP; the disease is glioma.